Crispr Therapeutics (NASDAQ:CRSP) Earning Somewhat Favorable News Coverage, Study Shows – The Ledger Gazette
Seeking Alpha |
Crispr Therapeutics (NASDAQ:CRSP) Earning Somewhat Favorable News Coverage, Study Shows
The Ledger Gazette Crispr Therapeutics logo Media headlines about Crispr Therapeutics (NASDAQ:CRSP) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than twenty million … Crispr Therapeutics (CRSP) Coverage Initiated by Analysts at Oppenheimer Crispr Therapeutics (CRSP) Earns News Sentiment Rating of 0.05 Crispr Therapeutics (CRSP) Coverage Initiated at Oppenheimer |
